@Article{Perricone2021,
journal="Reumatologia/Rheumatology Supplements",
issn="0034-6233",
year="2021",
title="Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19",
abstract="The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept the world in a pandemic. The disease (COVID-19) is characterized by acute respiratory distress, and there is an immediate need for any effective agent before the development of a vaccine. Coronavirus-19 disease (COVID-19) is an infectious disease caused by SARS-CoV-2, a -coronavirus which causes pneumonia, requires intensive care unit hospitalization in about 10% of cases and can lead to a fatal outcome [1].",
author="Perricone, Carlo
and Bartoloni, Elena
and Gerli, Roberto",
pages="261--264",
url="https://www.termedia.pl/Colchicine-an-anti-rheumatic-agent-as-a-potential-compound-for-the-treatment-of-COVID-19,48,45112,1,1.html"
}